circTUBD1 ‐ hnRNPK Regulates the Proliferation and Migration of LSCC by Targeting CCAR1
Cancer Medicine · 2025
DOI: 10.1002/cam4.70834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Yufeng Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, China. Hauptthemen laut MEDLINE: RNA, Circular, Heterogeneous-Nuclear Ribonucleoprotein K, Laryngeal Neoplasms, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Medical and Health Science Research Foundation, Ningbo Top Medical and Health Research Program, Ningbo Clinical Research Center for Otolaryngology Head and Neck Disease.
Abstract (Originalsprache)
Background
Laryngeal squamous cell carcinoma (LSCC) is one of the most prevalent malignancies of the head and neck region. Circular RNAs (circRNAs) have been found to exhibit abnormal expression patterns in various tumors and play pivotal roles in tumorigenesis and tumor progression.
Methods
Functional assays assessed proliferation, migration, and invasion. Mechanistic studies were performed to explore the interaction between circTUBD1 and heterogeneous nuclear ribonucleoprotein K (hnRNPK), as well as its regulation of Cell Cycle and Apoptosis Regulator 1 (CCAR1). In vivo experiments confirmed circTUBD1's role in tumor growth and metastasis.
Results
We discovered that circTUBD1 is significantly upregulated in LSCC and promotes the proliferation, invasion, and migration of LSCC cells. circTUBD1 forms a circRNA‐protein complex with hnRNPK and facilitates LSCC progression by regulating CCAR1. Furthermore, in vivo experiments in mice demonstrated that silencing circTUBD1 inhibits the proliferation and metastasis of LSCC.
Conclusions
This study provides evidence that circTUBD1 is a potential tumor marker for LSCC and underscores the therapeutic potential of targeting circTUBD1 in this cancer type.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, China.
ORCID-Profile: Zhisen Shen, Jingjing Chen
Förderung
- Zhejiang Provincial Medical and Health Science Research Foundation
- Ningbo Top Medical and Health Research Program
- Ningbo Clinical Research Center for Otolaryngology Head and Neck Disease
- Natural Science Foundation of Ningbo Municipality
Zitieren
APA
Xu, Y., Qiu, S., Shen, Z., & Chen, J. (2025). circTUBD1 ‐ hnRNPK Regulates the Proliferation and Migration of LSCC by Targeting CCAR1. Cancer Medicine. https://doi.org/10.1002/cam4.70834
Vancouver
Xu Y, Qiu S, Shen Z, Chen J. circTUBD1 ‐ hnRNPK Regulates the Proliferation and Migration of LSCC by Targeting CCAR1. Cancer Medicine. 2025. doi:10.1002/cam4.70834
BibTeX
@article{Xu2025,
author = {Xu, Yufeng and Qiu, Shijie and Shen, Zhisen and Chen, Jingjing},
title = {circTUBD1 ‐ hnRNPK Regulates the Proliferation and Migration of LSCC by Targeting CCAR1},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70834}
}
EUVIMED